Publications

Publications pour l'équipe Oncostat

Titre Publication Type Publication year Auteur
Erratum to: Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis journalArticle 2016 Lueza, B.; Rotolo, F.; Bonastre, J.; Pignon, J. P.; Michiels, S.
Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis journalArticle 2016 Lueza, B.; Rotolo, F.; Bonastre, J.; Pignon, J. P.; Michiels, S.
A Pharmacokinetic and Pharmacogenetic Analysis of Osteosarcoma Patients Treated With High-Dose Methotrexate: Data From the OS2006/Sarcoma-09 Trial journalArticle 2018 Lui, Gabrielle; Treluyer, Jean-Marc; Fresneau, Brice; Piperno-Neumann, Sophie; Gaspar, Nathalie; Corradini, Nadège; Gentet, Jean-Claude; Marec Berard, Perrine; Laurence, Valérie; Schneider, Pascale; Entz-Werle, Natacha; Pacquement, Hélène; Millot, Frédéric; Taque, Sophie; Freycon, Claire; Lervat, Cyril; Le Deley, Marie Cécile; Mahier Ait Oukhatar, Céline; Brugieres, Laurence; Le Teuff, Gwénaël; Bouazza, Naïm; Sarcoma Group of UNICANCER
[uPA/PAI-1, Oncotype DX™, MammaPrint(®). Prognosis and predictive values for clinical utility in breast cancer management] journalArticle 2015 Luporsi, E.; Bellocq, J. P.; Barrière, J.; Bonastre, J.; Chetritt, J.; Le Corroller, A. G.; de Cremoux, P.; Fina, F.; Gauchez, A. S.; Lamy, P. J.; Martin, P. M.; Mazouni, C.; Peyrat, J. P.; Romieu, G.; Verdoni, L.; Mazeau-Woynar, V.; Kassab-Chahmi, D.
Telomere shortening: a new prognostic factor for cardiovascular disease post-radiation exposure journalArticle 2015 M'Kacher, R.; Girinsky, T.; Colicchio, B.; Ricoul, M.; Dieterlen, A.; Jeandidier, E.; Heidingsfelder, L.; Cuceu, C.; Shim, G.; Frenzel, M.; Lenain, A.; Morat, L.; Bourhis, J.; Hempel, W. M.; Koscielny, S.; Paul, J. F.; Carde, P.; Sabatier, L.
Telomere shortening: a new prognostic factor for cardiovascular disease post-radiation exposure journalArticle 2015 M'Kacher, R.; Girinsky, T.; Colicchio, B.; Ricoul, M.; Dieterlen, A.; Jeandidier, E.; Heidingsfelder, L.; Cuceu, C.; Shim, G.; Frenzel, M.; Lenain, A.; Morat, L.; Bourhis, J.; Hempel, W. M.; Koscielny, S.; Paul, J. F.; Carde, P.; Sabatier, L.
Quality-of-Life Assessment in French Patients With Metastatic Melanoma in Real Life journalArticle 2020 M;Kandel, S;Dalle, A;Bardet, C;Allayous, L;Mortier, C;Dutriaux, B;Guillot, M;Leccia, S;Dalac, D;Legoupil, P;Saiag, H;Montaudie, JP;Arnault, F;B.Possenti, JJ;Grob, J;DeQuatrebarbes, M;Beylot-Barry, T;Lesimple, F;Aubin, E;Maubec, F;Granel-Brocard, PE;Stoebner, A;Dupuy, B;Dreno, S;Michiels, C;Lebbe, I;Borget
Prognostic and Predictive Effect of TP53 Mutations in Patients with Non-Small Cell Lung Cancer from Adjuvant Cisplatin-Based Therapy Randomized Trials: A LACE-Bio Pooled Analysis journalArticle 2016 Ma, X.; Le Teuff, G.; Lacas, B.; Tsao, M. S.; Graziano, S.; Pignon, J. P.; Douillard, J. Y.; Le Chevalier, T.; Seymour, L.; Filipits, M.; Pirker, R.; Janne, P. A.; Shepherd, F. A.; Brambilla, E.; Soria, J. C.; Hainaut, P.; Group, L. A. C. E. Bio Collaborative
Prognostic and Predictive Effect of TP53 Mutations in Patients with Non-Small Cell Lung Cancer from Adjuvant Cisplatin-Based Therapy Randomized Trials: A LACE-Bio Pooled Analysis journalArticle 2016 Ma, X.; Le Teuff, G.; Lacas, B.; Tsao, M. S.; Graziano, S.; Pignon, J. P.; Douillard, J. Y.; Le Chevalier, T.; Seymour, L.; Filipits, M.; Pirker, R.; Janne, P. A.; Shepherd, F. A.; Brambilla, E.; Soria, J. C.; Hainaut, P.; Group, L. A. C. E. Bio Collaborative
[Radiotherapy for nasopharyngeal carcinoma] journalArticle 2016 Maingon, P.; Blanchard, P.; Bidault, F.; Calmels, L.
Impact of prophylactic central neck dissection on oncologic outcomes of papillary thyroid carcinoma: a review journalArticle 2015 Mamelle, E.; Borget, I.; Leboulleux, S.; Mirghani, H.; Suárez, C.; Pellitteri, P. K.; Shaha, A. R.; Hamoir, M.; Robbins, K. T.; Khafif, A.; Rodrigo, J. P.; Silver, C. E.; Rinaldo, A.; Ferlito, A.; Hartl, D. M.
Impact of prophylactic central neck dissection on oncologic outcomes of papillary thyroid carcinoma: a review journalArticle 2015 Mamelle, E.; Borget, I.; Leboulleux, S.; Mirghani, H.; Suárez, C.; Pellitteri, P. K.; Shaha, A. R.; Hamoir, M.; Robbins, K. T.; Khafif, A.; Rodrigo, J. P.; Silver, C. E.; Rinaldo, A.; Ferlito, A.; Hartl, D. M.
[Standard or specific unit costs: Which criteria for choosing an economic evaluation of health strategies in multicentric studies?] journalArticle 2018 Margier, J.; Baffert, S.; Le Corroller-Soriano, A. G.
European cost-effectiveness study of uPA/PAI-1 biomarkers to guide adjuvant chemotherapy decisions in breast cancer journalArticle 2016 Marguet, S.; Mazouni, C.; Ramaekers, B. L.; Dunant, A.; Kates, R.; Jacobs, V. R.; Joore, M. A.; Harbeck, N.; Bonastre, J.
Strategies for Managing Intraoperative Discovery of Limited Colorectal Peritoneal Metastases journalArticle 2019 Mariani, A.; Gelli, M.; Sourrouille, I.; Benhaim, L.; Faron, M.; Honore, C.; Elias, D.; Goere, D.
Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study journalArticle 2018 Marino, P.; Touzani, R.; Perrier, L.; Rouleau, E.; Kossi, D. S.; Zhaomin, Z.; Charrier, N.; Goardon, N.; Preudhomme, C.; Durand-Zaleski, I.; Borget, I.; Baffert, S.
Designs of preoperative biomarkers trials in oncology: a systematic review of the literature journalArticle 2015 Marous, M.; Bieche, I.; Paoletti, X.; Alt, M.; Razak, A. R.; Stathis, A.; Kamal, M.; Le Tourneau, C.
INTRODUCTION OF INNOVATIVE MEDICAL DEVICES AT FRENCH UNIVERSITY HOSPITALS: AN OVERVIEW OF HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT INITIATIVES journalArticle 2015 Martelli, N.; Billaux, M.; Borget, I.; Pineau, J.; Prognon, P.; van den Brink, H.
INTRODUCTION OF INNOVATIVE MEDICAL DEVICES AT FRENCH UNIVERSITY HOSPITALS: AN OVERVIEW OF HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT INITIATIVES journalArticle 2015 Martelli, N.; Billaux, M.; Borget, I.; Pineau, J.; Prognon, P.; van den Brink, H.
A Systematic Review of the Level of Evidence in Economic Evaluations of Medical Devices: The Example of Vertebroplasty and Kyphoplasty journalArticle 2015 Martelli, N.; Devaux, C.; van den Brink, H.; Pineau, J.; Prognon, P.; Borget, I.
Combining multi-criteria decision analysis and mini-health technology assessment: A funding decision-support tool for medical devices in a university hospital setting journalArticle 2016 Martelli, N.; Hansen, P.; van den Brink, H.; Boudard, A.; Cordonnier, A. L.; Devaux, C.; Pineau, J.; Prognon, P.; Borget, I.
Advantages and disadvantages of 3-dimensional printing in surgery: A systematic review journalArticle 2016 Martelli, N.; Serrano, C.; van den Brink, H.; Pineau, J.; Prognon, P.; Borget, I.; El Batti, S.
New French Coverage with Evidence Development for Innovative Medical Devices: Improvements and Unresolved Issues journalArticle 2016 Martelli, N.; van den Brink, H.; Borget, I.
New French Coverage with Evidence Development for Innovative Medical Devices: Improvements and Unresolved Issues journalArticle 2016 Martelli, N.; van den Brink, H.; Borget, I.
Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel Disease journalArticle 2016 Marthey, L.; Mateus, C.; Mussini, C.; Nachury, M.; Nancey, S.; Grange, F.; Zallot, C.; Peyrin-Biroulet, L.; Rahier, J. F.; Bourdier de Beauregard, M.; Mortier, L.; Coutzac, C.; Soularue, E.; Lanoy, E.; Kapel, N.; Planchard, D.; Chaput, N.; Robert, C.; Carbonnel, F.
Long-term outcome of liver transplantation in childhood: A study of 20-year survivors journalArticle 2018 Martinelli, J.; Habes, D.; Majed, L.; Guettier, C.; Gonzalès, E.; Linglart, A.; Larue, C.; Furlan, V.; Pariente, D.; Baujard, C.; Branchereau, S.; Gauthier, F.; Jacquemin, E.; Bernard, O.
Phenotypic and genetic heterogeneity of tumor tissue and circulating tumor cells in patients with metastatic castration-resistant prostate cancer: A report from the PETRUS prospective study journalArticle 2016 Massard, C.; Oulhen, M.; Le Moulec, S.; Auger, N.; Foulon, S.; Abou-Lovergne, A.; Billiot, F.; Valent, A.; Marty, V.; Loriot, Y.; Fizazi, K.; Vielh, P.; Farace, F.
Phenotypic and genetic heterogeneity of tumor tissue and circulating tumor cells in patients with metastatic castration-resistant prostate cancer: A report from the PETRUS prospective study journalArticle 2016 Massard, C.; Oulhen, M.; Le Moulec, S.; Auger, N.; Foulon, S.; Abou-Lovergne, A.; Billiot, F.; Valent, A.; Marty, V.; Loriot, Y.; Fizazi, K.; Vielh, P.; Farace, F.
Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry journalArticle 2019 Matejcic, M.; Saunders, E. J.; Dadaev, T.; Brook, M. N.; Wang, K.; Sheng, X.; Olama, A. A. A.; Schumacher, F. R.; Ingles, S. A.; Govindasami, K.; Benlloch, S.; Berndt, S. I.; Albanes, D.; Koutros, S.; Muir, K.; Stevens, V. L.; Gapstur, S. M.; Tangen, C. M.; Batra, J.; Clements, J.; Gronberg, H.; Pashayan, N.; Schleutker, J.; Wolk, A.; West, C.; Mucci, L.; Kraft, P.; Cancel-Tassin, G.; Sorensen, K. D.; Maehle, L.; Grindedal, E. M.; Strom, S. S.; Neal, D. E.; Hamdy, F. C.; Donovan, J. L.; Travis, R. C.; Hamilton, R. J.; Rosenstein, B.; Lu, Y. J.; Giles, G. G.; Kibel, A. S.; Vega, A.; Bensen, J. T.; Kogevinas, M.; Penney, K. L.; Park, J. Y.; Stanford, J. L.; Cybulski, C.; Nordestgaard, B. G.; Brenner, H.; Maier, C.; Kim, J.; Teixeira, M. R.; Neuhausen, S. L.; De Ruyck, K.; Razack, A.; Newcomb, L. F.; Lessel, D.; Kaneva, R.; Usmani, N.; Claessens, F.; Townsend, P. A.; Gago-Dominguez, M.; Roobol, M. J.; Menegaux, F.; Khaw, K. T.; Cannon-Albright, L. A.; Pandha, H.; Thibodeau, S. N.; Schaid,
45 or 50 Gy, Which is the Optimal Radiotherapy Pelvic Dose in Locally Advanced Cervical Cancer in the Perspective of Reaching Magnetic Resonance Image-guided Adaptive Brachytherapy Planning Aims? journalArticle 2016 Mazeron, R.; Petit, C.; Rivin, E.; Limkin, E.; Dumas, I.; Maroun, P.; Annede, P.; Martinetti, F.; Seisen, T.; Lefkopoulos, D.; Chargari, C.; Haie-Meder, C.
Reduced acute toxicity and improved efficacy from intensity-modulated proton therapy (IMPT) for the management of head and neck cancer journalArticle 2016 McKeever, M. R.; Sio, T. T.; Gunn, G. B.; Holliday, E. B.; Blanchard, P.; Kies, M. S.; Weber, R. S.; Frank, S. J.
Reduced acute toxicity and improved efficacy from intensity-modulated proton therapy (IMPT) for the management of head and neck cancer journalArticle 2016 McKeever, M. R.; Sio, T. T.; Gunn, G. B.; Holliday, E. B.; Blanchard, P.; Kies, M. S.; Weber, R. S.; Frank, S. J.
[Data sources, the data used, and the modality for collection] journalArticle 2018 Mercier, G.; Costa, N.; Dutot, C.; Riche, V. P.
Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents journalArticle 2016 Merlevede, J.; Droin, N.; Qin, T.; Meldi, K.; Yoshida, K.; Morabito, M.; Chautard, E.; Auboeuf, D.; Fenaux, P.; Braun, T.; Itzykson, R.; de Botton, S.; Quesnel, B.; Commes, T.; Jourdan, E.; Vainchenker, W.; Bernard, O.; Pata-Merci, N.; Solier, S.; Gayevskiy, V.; Dinger, M. E.; Cowley, M. J.; Selimoglu-Buet, D.; Meyer, V.; Artiguenave, F.; Deleuze, J. F.; Preudhomme, C.; Stratton, M. R.; Alexandrov, L. B.; Padron, E.; Ogawa, S.; Koscielny, S.; Figueroa, M.; Solary, E.
Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents journalArticle 2016 Merlevede, J.; Droin, N.; Qin, T.; Meldi, K.; Yoshida, K.; Morabito, M.; Chautard, E.; Auboeuf, D.; Fenaux, P.; Braun, T.; Itzykson, R.; de Botton, S.; Quesnel, B.; Commes, T.; Jourdan, E.; Vainchenker, W.; Bernard, O.; Pata-Merci, N.; Solier, S.; Gayevskiy, V.; Dinger, M. E.; Cowley, M. J.; Selimoglu-Buet, D.; Meyer, V.; Artiguenave, F.; Deleuze, J. F.; Preudhomme, C.; Stratton, M. R.; Alexandrov, L. B.; Padron, E.; Ogawa, S.; Koscielny, S.; Figueroa, M.; Solary, E.
Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel-Lindau Gene Mutation Status journalArticle 2015 Messai, Y.; Gad, S.; Noman, M. Z.; Le Teuff, G.; Couve, S.; Janji, B.; Kammerer, S. F.; Rioux-Leclerc, N.; Hasmim, M.; Ferlicot, S.; Baud, V.; Mejean, A.; Mole, D. R.; Richard, S.; Eggermont, A. M.; Albiges, L.; Mami-Chouaib, F.; Escudier, B.; Chouaib, S.
Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel-Lindau Gene Mutation Status journalArticle 2015 Messai, Y.; Gad, S.; Noman, M. Z.; Le Teuff, G.; Couve, S.; Janji, B.; Kammerer, S. F.; Rioux-Leclerc, N.; Hasmim, M.; Ferlicot, S.; Baud, V.; Mejean, A.; Mole, D. R.; Richard, S.; Eggermont, A. M.; Albiges, L.; Mami-Chouaib, F.; Escudier, B.; Chouaib, S.
All simulation models of breast cancer are wrong but some are useful journalArticle 2018 Michiels, S.; Delaloge, S.
Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer journalArticle 2016 Michiels, S.; Pugliano, L.; Marguet, S.; Grun, D.; Barinoff, J.; Cameron, D.; Cobleigh, M.; Di Leo, A.; Johnston, S.; Gasparini, G.; Kaufman, B.; Marty, M.; Nekljudova, V.; Paluch-Shimon, S.; Penault-Llorca, F.; Slamon, D.; Vogel, C.; von Minckwitz, G.; Buyse, M.; Piccart, M.
Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer journalArticle 2016 Michiels, S.; Pugliano, L.; Marguet, S.; Grun, D.; Barinoff, J.; Cameron, D.; Cobleigh, M.; Di Leo, A.; Johnston, S.; Gasparini, G.; Kaufman, B.; Marty, M.; Nekljudova, V.; Paluch-Shimon, S.; Penault-Llorca, F.; Slamon, D.; Vogel, C.; von Minckwitz, G.; Buyse, M.; Piccart, M.